GAVISCON ADVANCE LIQUID is a brand name for Potassium Bicarbonate. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Treatment of symptoms of gastro-oesophageal reflux such as acid regurgitation, heartburn and indigestion (related to reflux), for example, following meals, or during pregnancy, or in patients with symptoms related to reflux oesophagitis
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults and children 12 years and over: 5 – 10 ml after meals and at bedtime.
Children under 12 years:
Should only be given on medical advice.
Duration of treatment:
If symptoms do not improve after seven days, the clinical situation should be reviewed.
Special patient groups:
Elderly: No dose modifications necessary for this age group.
Hepatic Impairment:
No modifications necessary. 4). Method of administration For oral use. Any unused solution should be discarded.
Adverse reactions have been ranked under headings of frequency using the following convention: very common (1/10), common (1/100 and <1/10), uncommon (1/1000 and <1/100), rare (1/10,000 and <1/1000), very rare (<1/10,000) and not known (cannot be estimated from the available data).
System Organ Class Frequency Adverse Event Gastrointestinal Disorders Uncommon Diarrhoea, nausea, Vomiting Immune System Disorders Very rare Anaphylactic and anaphylactoid reactions. Hypersensitivity reactions such as urticaria. Respiratory, Thoracic and Mediastinal Disorders Very rare Respiratory effects such as bronchospasm.
Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
4 Special Warnings and Special Precautions for Use If symptoms do not improve after seven days, the clinical situation should be reviewed. 0 mmol) of calcium. Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis and recurrent calcium containing renal calculi.
This medicinal product contains Methyl hydroxybenzoate and Propyl hydroxybenzoate, which may cause allergic reactions (possibly delayed). 2. 9% of the WHO recommended maximum daily intake of sodium. 14% of the WHO recommended maximum daily intake for sodium.
This is based on a 10ml dose taken four times per day This product is considered high in sodium. g. in some cases of congestive heart failure and renal impairment) or when taking drugs which can increase plasma potassium levels. 06 mg) per 5 ml.
To be taken into consideration by patients with reduced kidney function or patients on a controlled potassium diet.
4).
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Potassium Bicarbonate in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.